UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000011235 |
|---|---|
| Receipt number | R000013103 |
| Scientific Title | Phase II study for the evaluation of personalized sVCD-sVTD sequential therapy using VES-13 for newly diagnosed transplant-ineligible multiple myeloma |
| Date of disclosure of the study information | 2013/07/23 |
| Last modified on | 2022/08/13 11:54:24 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2013/07/19 23:17:39 | ||
| 2 | Update | 2013/07/23 05:50:24 | Narrative objectives1 Key secondary outcomes |
|
| 3 | Update | 2013/07/23 05:51:48 | Recruitment status |
|
| 4 | Update | 2014/03/04 22:41:43 | Target sample size |
|
| 5 | Update | 2014/06/05 23:02:58 | Email Institute Institute |
|
| 6 | Update | 2022/08/13 11:09:56 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Address Address TEL Last name of contact person Last name of contact person Zip code Address Address TEL Address Address TEL Name of primary person or sponsor Organization Organization Organization Address Address Tel |
|
| 7 | Update | 2022/08/13 11:12:40 | Recruitment status Date of IRB Last follow-up date |
|
| 8 | Update | 2022/08/13 11:54:24 | URL releasing protocol Publication of results URL related to results and publications Number of participants that the trial has enrolled Results Results Results date posted Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
